Research > Cancer

Research group of Cancer Biomarkers (GReBiC)

Number of publications
482
Publications search
  • Xu, CM; Mannucci, A; Esposito, F; Oliveres, H; Alonso-Orduña, V; Yubero, A; Fernández-Martos, C; Salud, A; Gallego, J; Martín-Richard, M; Fernández-Plana, J; Guillot, M; Aparicio, J; Fakih, M; Kopetz, S; Feliu, J; Maurel, J; Goel, A

    An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study

    CLINICAL CANCER RESEARCH 31 1002-1015. .

    [doi:10.1158/1078-0432.CCR-24-1934]

  • García-Alfonso, P; Elez, E; Soto-Alsar, J; Páez, D; Fernández-Montes, A; Graña, B; Salud, A; Yubero, A; Gómez-España, MA; Macías, I; Quintero, G; López-López, C; Fernández-Rodríguez, T; Grávalos, C; González-Flores, E; Guix, M; Paredes, BG; Reina, JJ; Mowbray, JRR; Sastre, J; Aranda, E

    Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial

    ESMO Open 9 103986-103986. .

    [doi:10.1016/j.esmoop.2024.103986]

  • Pont, M; Marqués, M; Sorolla, A

    Latest Therapeutical Approaches for Triple-Negative Breast Cancer: From Preclinical to Clinical Research

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 25 -. .

    [doi:10.3390/ijms252413518]

  • Rendón-Ramírez EJ; Morales-García AM; Rendón-Pérez A; Nañez-Terreros H; Solis RC; Magaña-García AD; Medrano-Juárez S; Caloca-Estrada JF; Mercado-Longoria R; Leija-Herrera JE; Porcel JM

    Pleural Effusion Identified by Point of Care Ultrasound (POCUS) in Septic Shock: Impact on Clinical Outcomes.

    Pocus Journal 9 55-61. .

    [doi:10.24908/pocus.v9i2.17293]

  • Rendón-Ramíreza, E; Fraga-Enríquez, V; Colunga-Pedraza, PR; Nañez-Terreros, H; Flores-Ramírez, R; Cansecob, F; Porcele, JM; Carrizales-Sepúlveda, E

    Pleural effusions identified by thoracic ultrasound predict poor quality of life in patients with acute decompensated heart failure

    HEART & LUNG 68 279-283. .

    [doi:10.1016/j.hrtlng.2024.08.008]

  • Hidalgo, I; Sorolla, MA; Sorolla, A; Salud, A; Parisi, E

    Secreted Phospholipases A2: Drivers of Inflammation and Cancer

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 25 -. .

    [doi:10.3390/ijms252212408]

  • Gómez, JC; Viñas, MMC; Pérez, JMP; Bailón, MM; Martínez, PP; Marín, MTH; Somoza, FJE

    Strategic framework for the Spanish Society of Internal Medicine. 2025-2029. Executive summary on guaranteeing person-centered care in a high value National Health System

    REVISTA CLINICA ESPANOLA 224 609-622. .

    [doi:10.1016/j.rce.2024.08.001]

  • Gardiner, A; Ling, R; Chan, YH; Porcel, J; Lee, YCG; Teoh, CM; Liew, MF; Kapur, J; Low, SP; Lee, P

    DUETS for Light's in separating exudate from transudate

    RESPIROLOGY 29 976-984. .

    [doi:10.1111/resp.14780]

  • Fullana, B; Morales, S; Petit, A; Alay, A; Verdaguer, H; Climent, F; Navarro-Perez, V; Cejuela, M; Galvan, P; Gumà, A; Llombart-Cussac, A; Cordero, D; Casanovas, O; Prat, A; Gil-Gil, M; Pernas, S

    Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial

    SCIENTIFIC REPORTS 14 -. .

    [doi:10.1038/s41598-024-72152-1]

  • Rodríguez, JV; Prieto, A; Vilaprinyo, E; Bonet, M; Diez, M; Salud, A; Montal, R

    Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis (vol 201, 104416, 2024)

    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 202 104466-104466. .

    [doi:10.1016/j.critrevonc.2024.104466]

  • Pardessus Otero A; Rafecas-Codern A; Porcel JM; Serra-Mitjà P; Ferreiro L; Botana-Rial M; Ramos-Hernández C; Brenes JM; Canales L; Camacho V; Romero-Romero B; Trujillo JC; Martinez E; Cases E; Barba A; Majem M; Güell E; Pajares V

    Malignant Pleural Effusion: A Multidisciplinary Approach.

    Open Respiratory Archives 6 100349-100349. .

    [doi:10.1016/j.opresp.2024.100349]

  • Alés-Martínez, JE; Balmaña, J; Sánchez-Rovira, P; Bofill, FJS; Sáenz, JAG; Pimentel, I; Morales, S; Fernández-Abad, M; Martínez, AL; Ferrer, N; Zamora, P; Bermejo, B; Diaz-Redondo, T; López-Ceballos, MH; Galán, M; Pérez-Escuredo, J; Calabuig, L; Sampayo, M; Pérez-Garcia, JM; Cortés, J; Llombart-Cussac, A

    Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study

    BREAST 77 103780-103780. .

    [doi:10.1016/j.breast.2024.103780]